Applying risk assessment models in orthopaedic surgery: Effective risk stratification

Blood Coagulation and Fibrinolysis

Volumn 10, Issue 6 SUPPL. 2, 1999, Pages

  Cohen, A T ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antithrombotic agents; Deep vein thrombosis; Orthopaedic surgery; Prophylaxis; Risk factors; Risk prediction; Trauma

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DESULFATOHIRUDIN; HEPARIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; PENTASACCHARIDE; THROMBIN INHIBITOR;

COMPRESSION THERAPY; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; HUMAN; LUNG EMBOLISM; ORAL DRUG ADMINISTRATION; ORTHOPEDIC SURGERY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA; TRAUMATOLOGY; TREATMENT FAILURE; TREATMENT PLANNING;

HUMANS; ORTHOPEDICS; PULMONARY EMBOLISM; RISK ASSESSMENT; VENOUS THROMBOSIS;

EID: 0032834632     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (61)

1. Nicolaides AN, Bergqvist D, Hull R, Ackchurin RS, Allegra C, Arcelus J, et al. Consensus statement: prevention of venous thromboembolism. Int Angiol 1997; 16: 3-38.
2. Clagett GP, Anderson FA, Heit J, Levine MN, Wheeler HB. Prevention of venous thromboembolism. Chest 1995; 108 (suppl): 312S-334S.
3. Salzman EW, Hirsh J. The epidemiology, pathogenesis, and natural history of venous thrombosis. In: Colman RW, Hirsh J, Marder VJ, et al. (editors). Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 3rd edition. Philadelphia: Lippincott, 1994; 1275-1296.
4. Hull R, Raskob G, Pinco G, Rosenbloom D, Evans W, Mallory T, et al. A comparison of subcutaneous low molecular weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993; 329: 1370-1376.
5. Geerts WH, Jay RM, Code KI, Chen, E, Szalai JP, Saibil EA, Hamilton PA. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 1996; 335; 701-707.
6. Agnelli G, Sonaglia F. Prevention of venous thromboembolism in high risk patients. Haematologica 1997; 82: 496-502.
7. Storti S, Crucitti P, Cina G. Risk factors and prevention of venous thromboembolism. RAYS 1996; 21: 439-460.
8. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J Royal Soc Med 1989; 82: 203-205.
9. Demers C, Marcoux S, Ginsberg JS, Laroche F, Cloutier R, Poulin J. Incidence of venographically proved deep vein thrombosis after knee arthroscopy. Arch Intern Med 1998; 158: 47-50.
10. Anderson FA Jr, Wheeler IIB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan NA. Physician practices in the prevention of venous thromboembolism. Arch Intern Med 1991; 115: 591-595.
11. Anderson FA Jr, Wheeler HB, Goldberg, RJ, Hosmer DW, Forcier A, Patwardhan NA. Prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism. Arch Intern Med 1994; 154: 669-677.
12. Nurmohamed M, Rosendal F, Buller H, Dekker E, Hommes D, Vandenborucke, Briet E. Low molecular weight heparin versus standard heparin in general and orthopedic surgery. A meta-analysis. Lancet 1992; 340: 152-156.
13. Leizorovicz A, Haugh MC, Chapuis F-R, Samama M, Boisel J-P. Low molecular weight heparin in prevention of perioperative thrombosis. BMJ 1992; 305: 913-920.
14. Jørgensen LN, Wille-Jørgensen P, Hauch O. Prophylaxis of postoperative thromboembolism with low molecular weight heparins. Br J Surg 1993; 80: 689-704.
15. Kearon C, Hirsh J. Starting prophylaxis for venous thromboembolism postoperatively. Arch Intern Med 1995; 155: 366-372.
16. Planés A, Vochelle N, Darmon J-Y, Fagola M, Bellaud M, Compan D, et al. Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. Drugs 1996; 52 (suppl 7): 47-54.
17. Bergqvist D, Benoni G, Bjorgell O, Fredin H, Hedlundh U, Nicolas S, et al. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996; 335: 696-700.
18. Dahl OE, Andreassen G, Aspelin T, Muller C, Mathiesen P, Nyhus S, et al. Prolonged thromboprophylaxis following hip replacement surgery - results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin). Thromb Haemost 1997; 77: 26-31.
19. Lassen MR, Borris LC, for the Danish Prolonged Prophylaxis Study Group. Prolonged thromboprophylaxis with low molecular weight heparin (Fragmin) after elective total hip arthroplasty - a placebo-controlled study. Thromb Haemost 1995; 73: 1104 (Abstract).
20. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. III. Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994; 308: 235-246.
21. Kalodiki E Ph, Hoppensteadt DA, Nicolaides AN, Fareed J, Gill K, Regan F, et al. Deep venous thrombosis prophylaxis with low molecular weight heparin and elastic compression in patients having total hip replacement. Int Angiol 1996; 15: 162-168.
22. Nicolaides AN. Combined methods. In: Bergqvist D, Comerota A, Nicolaides A, Scurr J, (editors). Prevention of Venous Thromboembolism. London: Med-Orion Publishing, 1994; 225-234.
23. Chapuis Y, The Comité Scientifique Thrombose de PAH-HP. Prophylaxie des thromboses veineuses postoperatoires: recommandations de l'Assistance publique-Hopitaux de Paris. Sang Thromb Vaiss 1995; 7: 119-120.
24. Boneu B. New antithrombotic agents for the prevention and treatment of deep vein thrombosis. Haemostasis 1996; 26 (suppl 4): 368-378.
25. Eriksson BI, Wille-Jørgensen P, Kalebo P, Mouret P, Rosencher N, Bosch P, et al. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med 1997; 337: 1329-1335.
26. Brandjes DPM, ten Cate JW, Buller HR. Pre-surgical identification of the patient at risk for developing venous thromboembolism post-operatively. Acta Chir Scand 1996; 556 (suppl): 18-21.
27. Clayton JK, Anderson JA, McNicol GP. Pre-operative prediction of post-operative deep vein thrombosis. BMJ 1976; 16: 910-912.
28. Grandon AJ, Peel KR, Anderson JA, Thompson V, McNicol GP. Post-operative deep vein thrombosis: identifying high-risk patients. BMJ 1980; 281: 343-344.
29. Bergqvist D. Prolonged prophylaxis in postoperative medicine. Semin Thromb Hemost 1997; 23: 149-154.
30. Paiement GD. Thromboembolic complications following trauma surgery: incidence and outcomes. Orthopedics 1995; 18 (suppl): 12-14.
31. Dahl OE, Aspelin T, Lyberg T. The role of bone traumatization in the initiation of proximal deep vein thrombosis curing cemented hip replacement surgery in pigs. Blood Coagul Fibrinolysis 1995; 6: 709-717.
32. Eriksson B, Eriksson E, Gyzander E, Teger-Nilsson A-C, Risberg B. Thrombosis after hip replacement. Acta Orthop Scand 1989; 60: 159-163.
33. Comerota A, Stewart GJ, Alburger PD. Operative venodilation: a previously unsuspected factor in the course of postoperative deep vein thrombosis. Surgery 1989; 106: 301-309.
34. Planés A, Vochelle N, Fagola M. Total hip replacement and deep vein thrombosis: a venographic and necropsy study. J Bone Joint Surg 1990; 72-B: 9-13.
35. Davis FM, Laurenson VG, Gillespie WJ, Foate J, Seagers D. Leg blood flow during total hip replacement under spinal or general anaesthesia. Anaesth Intensive Care 1989; 17: 136-143.
36. Francis CW, Marder V, Evarts CM. Lower risk of thromboembolic disease after total hip replacement with non-cemented than with cemented prosthesis. Lancet 1986; i: 769-771.
37. THRIFT Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ 1992; 305: 567-574.
38. Hunt BJ, Doughty H-A, Majumdar G, Copplestone A, Kerslake S, Buchanan N, et al. Thromboprophylaxis with low molecular weight heparin in high risk pregnancies. Thromb Haemost 1997; 77: 39-43.
39. Simmons AV, Sheppard MA, Cox AF. Deep venous thrombosis after myocardial infarction: predisposing factors. Br Heart J 1973; 35: 623-625.
40. Noel P, Gregoire F, Capon A, Lehert P. Atrial fibrillation as a risk factor for deep venous thrombosis and pulmonary emboli in stroke patients. Stroke 1991; 22: 760-762.
41. Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 1983; 622: 14-31.
42. Cortellazzo S, Viero P, Finazzi G, D'Emilio A, Rodeghiero F, Barbui T. Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J Clin Oncol 1990; 8: 556-562.
43. Wiedmer T, Hall SE, Ortel TL, Kane WH, Rosse WF, Sims PJ. Complement-induced vesiculation and exposure of membrane prothombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood 1993; 82: 1196-1206.
44. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990; 112: 687-698.
45. Egeberg O. Inherited antithrombin III deficiency causing thrombophilia. Thromb Diathes Hemorrh 1965; 13: 516-520.
46. Mannucci PM, Vigano S. Deficiencies of protein C, an inhibitor of blood coagulation. Lancet 1982; ii:463-467.
47. Comp PC, Esmon CT. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med 1984; 311: 1525-1528.
48. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
49. Tuddenham EGD. Thrombophilia; the new factor is old factor V. Lancet 1994; 343: 1515-1516.
50. den Heijer M, KosterT, Blom HJ, Bos GM, Briet E, Reitsma PH, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759-762.
51. Hajjar KA, Nachman RL. The role of lipoprotein (a) in atherogenesis and thrombosis. Annu Rev Med 1996; 47: 423-442.
52. Angles-Cano E, Gris JC, Loyau S, Schved JF. Familial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism. J Lab Clin Med 1993; 121: 646-653
53. Tobelem G. Molecular basis of thrombosis. Nouv Rev Fr Hematol 1991; 33: 71-75.
54. Svensson PJ, Benono G, Fredin H, Bjorgell O, Nilsson P, Hedlund U, et al. Female gender and resistance to activated protein C as potential risk factors for thrombosis after elective hip arthroplasty. Thromb Haemost 1997; 78: 993-996.
55. Samama MM, Conard J, Horellou MH, Toulemonde F. Coagulation abnormalities predisposing to the development of deep vein thrombosis. In: Bergqvist D, Comerota A, Nicolaides A, Scurr J, (editors). Prevention of Venous Thromboembolism. London: Med-Orion Publishing, 1994; 43-56.
56. Bongard O, Wicky J, Peter R, Simonovska S, Vogel J-J, de Moerloose P, et al. D-dimer plasma measurement in patients undergoing major hip surgery: use in prediction and diagnosis of postoperative proximal vein thrombosis. Thromb Res 1994; 74: 487-493.
57. Falanga A, Ofosu FA, Cortelazzo S, Delaini F, Consonni R, Caccia R, et al. Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery. Br J Haem 1993; 85: 745-750.
58. Ginsberg JS, Brill-Edwards P, Panju A, Patel A, McGinnis J, Smith F, at al. Pre-operative plasma levels of thrombin-antithrombin III complexes correlate with the development of venous thrombosis after major hip or knee surgery. Thromb Haemost 1995; 74: 602-605.
59. Hoek JA, Nurmohamed MT, ten Cate JW, Buller HR, Knipscheer HC, Hamelynek KJ, et al. Thrombin-antithrombin III complexes in the prediction of deep vein thrombosis following total hip replacement. Thromb Haemost 1989; 62: 1050-1052.
60. Rowbotham BJ, Whitaker AN, Harrison J, Murtaugh P, Reasbeck P, Bowie EJW. Measurement of cross-linked fibrin derivatives in patients undergoing abdominal surgery: use in the diagnosis of postoperative venous thrombosis. Blood Coag Fibrinolysis 1992; 3: 25-31.
61. Cofrancesco E, Cortellaro M, Corradi A, Ravasi F, Bertocchi F. Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery. Thromb Haemost 1997; 77: 267-269.